Bank of New York Mellon’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q1 | – | Sell |
-1,038,102
| Closed | -$17.6M | – | 4303 |
|
|
2014
Q4 | $17.6M | Buy |
1,038,102
+7,589
| +0.7% | +$129K | ﹤0.01% | 1564 |
|
|
2014
Q3 | $12.3M | Buy |
1,030,513
+195,910
| +23% | +$2.34M | ﹤0.01% | 1767 |
|
|
2014
Q2 | $4.71M | Buy |
834,603
+8,994
| +1% | +$50.7K | ﹤0.01% | 2354 |
|
|
2014
Q1 | $3.03M | Buy |
825,609
+19,248
| +2% | +$70.6K | ﹤0.01% | 2600 |
|
|
2013
Q4 | $2.71M | Sell |
806,361
-8,716
| -1% | -$29.3K | ﹤0.01% | 2687 |
|
|
2013
Q3 | $3.45M | Buy |
815,077
+24,433
| +3% | +$103K | ﹤0.01% | 2479 |
|
|
2013
Q2 | $3.64M | Buy |
+790,644
| New | +$3.64M | ﹤0.01% | 2383 |
|